Modeling Cancer Outcomes and Economic Impact of the Anti-PD-1/PD-L1 Immunotherapy in the Gulf: United Arab Emirates, Oman, and Kuwait
- DOI
- 10.1007/s40261-026-01577-5
- Published
- 2026-08-12
- Container
- Clinical Drug Investigation
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40261-026-01577-5,
title = {Modeling Cancer Outcomes and Economic Impact of the Anti-PD-1/PD-L1 Immunotherapy in the Gulf: United Arab Emirates, Oman, and Kuwait},
author = {Humaid O. Al-Shamsi and Mohamed Farghaly and Ammar Abdaljalil and Abdulwahab Al-Tourah and Chana Saad and Youmna Bassil and Ghadah Albassam and Rami Nimer and Monika Naroz and Omar El-Badry and Rony Akel},
year = {2026},
journal = {Clinical Drug Investigation},
doi = {10.1007/s40261-026-01577-5},
url = {https://doi.org/10.1007/s40261-026-01577-5}
}RIS
TY - JOUR TI - Modeling Cancer Outcomes and Economic Impact of the Anti-PD-1/PD-L1 Immunotherapy in the Gulf: United Arab Emirates, Oman, and Kuwait AU - Humaid O. Al-Shamsi AU - Mohamed Farghaly AU - Ammar Abdaljalil AU - Abdulwahab Al-Tourah AU - Chana Saad AU - Youmna Bassil AU - Ghadah Albassam AU - Rami Nimer AU - Monika Naroz AU - Omar El-Badry AU - Rony Akel PY - 2026 JO - Clinical Drug Investigation DO - 10.1007/s40261-026-01577-5 UR - https://doi.org/10.1007/s40261-026-01577-5 ER -
APA
Al-Shamsi, H. O., Farghaly, M., Abdaljalil, A., Al-Tourah, A., Saad, C., Bassil, Y., Albassam, G., Nimer, R., Naroz, M., El-Badry, O., & Akel, R. (2026). Modeling Cancer Outcomes and Economic Impact of the Anti-PD-1/PD-L1 Immunotherapy in the Gulf: United Arab Emirates, Oman, and Kuwait. Clinical Drug Investigation. https://doi.org/10.1007/s40261-026-01577-5
Source records
- crossref · retrieved 2026-09-25T07:38:41.916Z